MicroRNA-9 as a novel prognostic biomarker in human laryngeal squamous cell carcinoma

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5523-5528

  Wu, Shuo ^a   Xu, Ping ^a   Jia, Shenshan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Laryngeal squamous cell carcinoma; MicroRNA; MiR 9; Prognostic biomarker

Indexed keywords

MICRORNA 9;

ADULT; AGE; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CELL INVASION; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LARYNX CARTILAGE; LARYNX SQUAMOUS CELL CARCINOMA; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE; TELEPHONE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; UPREGULATION;

EID: 84921534975     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Genden EM, Ferlito A, Silver CE, Jacobson AS, Werner JA, Suarez C, Leemans CR, Bradley PJ, Rinaldo A. Evolution of the management of laryngeal cancer. Oral Oncol 2007; 43: 431-439.
2. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
3. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Jo-hnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773.
4. Shigehara K, Yokomuro S, Ishibashi O, Mizugu-chi Y, Arima Y, Kawahigashi Y, Kanda T, Akagi I, Tajiri T, Yoshida H, Takizawa T, Uchida E. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One 2011; 6: e23584.
5. Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting ce-ll motility. Med Oncol 2012; 29: 1037-1043.
6. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadhe-rin and cancer metastasis. Nat Cell Biol 2010; 12: 247-256.
7. Nass D, Rosenwald S, Meiri E, Gilad S, Tabi-bian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwi-ck Yanai G, Elyakim E, Cholakh H, Gibori H, Spector Y, Bentwich Z, Barshack I, Rosenfeld N. MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 2009; 19: 375-383.
8. Zhang SY, Lu ZM, Luo XN, Chen LS, Ge PJ, Song XH, Chen SH, Wu YL. Retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment. PLoS One 2013; 8: e60157.
9. Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M. Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer 2005; 41: 683-693.
10. Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
11. Lohynska R, Slavicek A, Bahanan A, Novakova P. Predictors of local failure in early laryngeal cancer. Neoplasma 2005; 52: 483-488.
12. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
13. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
14. Sun X, Song Y, Tai X, Liu B, Ji W. MicroRNA expression and its detection in human supraglottic laryngeal squamous cell carcinoma. Bi-omed Rep 2013; 1: 743-746.
15. Wu TY, Zhang TH, Qu LM, Feng JP, Tian LL, Zhang BH, Li DD, Sun YN, Liu M. MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int J Clin Exp Pathol 2014; 7: 56-63.
16. Laneve P, Gioia U, Andriotto A, Moretti F, Bo-zzoni I, Caffarelli E. A minicircuitry involving RE-ST and CREB controls miR-9-2 expression during human neuronal differentiation. Nucleic Acids Res 2010; 38: 6895-6905.
17. Packer AN, Xing Y, Harper SQ, Jones L, Davi-dson BL. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is do-wnregulated in Huntington’s disease. J Ne-urosci 2008; 28: 14341-14346.
18. Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, Sayed S, Leoncini L. Al-teration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One 2010; 5.
19. Hildebrandt MA, Gu J, Lin J, Ye Y, Tan W, Tam-boli P, Wood CG, Wu X. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with cl-ear cell renal cell carcinoma. Oncogene 2010; 29: 5724-5728.
20. Luo H, Zhang H, Zhang Z, Zhang X, Ning B, Guo J, Nie N, Liu B, Wu X. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 2009; 28: 82.
21. Khew-Goodall Y, Goodall GJ. Myc-modulated miR-9 makes more metastases. Nat Cell Biol 2010; 12: 209-211.
22. Tan HX, Wang Q, Chen LZ, Huang XH, Chen JS, Fu XH, Cao LQ, Chen XL, Li W, Zhang LJ. Mi-croRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol 2010; 27: 654-660.
23. Zhou X, Marian C, Makambi KH, Kosti O, Kal-lakury BV, Loffredo CA, Zheng YL. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One 2012; 7: e39011.
24. Xu T, Liu X, Han L, Shen H, Liu L, Shu Y. Up-re-gulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin Transl Oncol 2014; 16: 469-475.
25. Wu Z, Wang L, Li G, Liu H, Fan F, Li Z, Li Y, Gao G. Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma. Mol Cell Biochem 2013; 384: 263-268.